Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

GNAS Gene Pseudohypoparathyroidism Type 1A Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين GNAS لقصور الدريقات الكاذب النمط 1أ بتقنية التسلسل الجيني NGS في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

Executive Summary

  • Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing. (ضمان الدقة: حساسية تشخيصية 99.9% عبر معالجة معتمدة من ISO)
  • Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy. (نقل فاخر: خدمة سحب منزلي بمعايير المستشفى ونقل العينات بسلسلة تبريد معتمدة)
  • Clinical Guidance: Telephonic Post-Test Clinical Guidance in Result Interpretation. (إرشاد سريري: استشارة هاتفية بعد الفحص لتفسير النتائج)
  • Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731. (التأمين: التحقق المباشر من تغطية التأمين عبر واتساب +971 54 548 8731)
ملخص تنفيذي معتمد من هيئة الصحة بدبي وفق المرسوم بقانون اتحادي رقم 41 لسنة 2024 وقانون خصوصية البيانات.
Regulatory Compliance: This test adheres to Federal Decree-Law No. 41 of 2024 (Art. 87), CDS Law 2026 (Minors), and UAE PDPL. Accredited under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).

Overview

The GNAS Gene Pseudohypoparathyroidism Type 1A NGS Test is a next-generation sequencing analysis that detects pathogenic variants in the GNAS gene, enabling definitive diagnosis of this rare endocrine disorder. يكشف هذا الفحص الجيني طفرات جين GNAS المسببة لقصور الدريقات الكاذب النمط 1أ.

Feature Our Test Closest Alternative
Precision Full-gene NGS coverage with copy-number analysis Single-gene Sanger sequencing (limited to known hotspots)
Methodology Next-Generation Sequencing (NGS) Targeted Mutation Panel
Turnaround Time 3 to 4 Weeks 6–8 Weeks (depending on lab)

Physician Insight & Safety Protocol

Dr. PRABHAKAR REDDY (DHA License: 61713011, Consultant Clinical Geneticist):

“As a clinical geneticist, I understand the anxiety surrounding genetic testing for Pseudohypoparathyroidism Type 1A. This NGS analysis targets the GNAS gene for precise diagnosis, but results must be correlated with clinical and biochemical findings. Please consult your endocrinologist for comprehensive interpretation and management.”

⚠ DO NOT discontinue prescribed medication without consulting your doctor. This genetic test is not a substitute for ongoing endocrine care.

Exclusion Criteria & Emergency Red Flags

  • Recent hematopoietic stem cell transplant (may confound genetic analysis). Consult lab before testing.
  • If the patient experiences severe hypocalcemic symptoms (tingling around mouth, muscle spasms, seizures, irregular heartbeat), seek emergency medical care immediately.
  • This test is not validated for prenatal diagnosis in the absence of a known familial mutation. Genetic counselling is mandatory before sample collection.

Patient FAQ & Clinical Guidance

1. What is GNAS gene pseudohypoparathyroidism type 1A, and how does this test diagnose it?

Pseudohypoparathyroidism Type 1A is an inherited disorder caused by inactivating mutations in the GNAS gene, leading to hormone resistance and features of Albright's hereditary osteodystrophy. This test uses Next-Generation Sequencing to read the entire GNAS coding region, identifying single-nucleotide variants, small insertions/deletions, and copy-number changes, providing a molecular diagnosis with >99% analytical sensitivity. يعتمد الفحص على التسلسل الجيني الكامل لجين GNAS لاكتشاف الطفرات المسببة.

2. How long does it take to receive results, and what does the process involve?

Results are typically available in 3 to 4 weeks from the date the laboratory receives your blood, extracted DNA, or dried blood spot on an FTA card. The process includes pre-test genetic counselling, sample collection (home or clinic), NGS library preparation, sequencing, bioinformatic analysis, and a final clinical report signed by a board-certified geneticist. مدة النتائج من ٣ إلى ٤ أسابيع، مع استشارة وراثية قبل الفحص.

3. Does insurance cover this genetic, and what happens after a positive result?

Coverage depends on your policy; we provide direct billing verification via WhatsApp at +971 54 548 8731 and work with major UAE insurers under DHA guidelines. A positive result confirms the diagnosis and triggers genetic counselling, family screening, and personalised endocrine management, all coordinated through licensed specialists committed to UAE PDPL data privacy. يتم التحقق من التغطية التأمينية وتقديم الاستشارة الوراثية بعد النتيجة الإيجابية.

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians